Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With

Min-Su Kim1, Brandon Fleres2, Jerrell Lovett2

  • 1Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Medical College of Wisconsin, Herma Heart Institute, Milwaukee, WI, United States.

Insights

Genetic variants in MYH6 cause hypoplastic left heart syndrome (HLHS) by disrupting sarcomere structure and contractility in atrial cardiomyocytes. This study used patient-derived stem cells to reveal the mechanism behind this severe congenital heart defect.

Area of Science:

  • Cardiology
  • Genetics
  • Developmental Biology

Background:

  • Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect with unknown etiology.
  • Genetic variants in the MYH6 gene have been previously associated with HLHS.
  • Patient-derived induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offer a model to study HLHS pathogenesis.

Purpose of the Study:

  • To investigate the functional impact of the MYH6-R443P variant on cardiomyocyte structure and function.
  • To elucidate the role of MYH6 variants in the development of HLHS.
  • To establish a cellular model for studying HLHS using iPSC-CMs.

Main Methods:

  • Generation and analysis of iPSC-CMs from an HLHS-affected family trio.
  • Assessment of sarcomere structure, gene expression (MYH7), and cellular contractility.
  • CRISPR/Cas9 gene editing to introduce and correct the MYH6-R443P variant.
  • Comparison of iPSC-CMs with patient cardiac tissues (atrial and ventricular).

Main Results:

  • iPSC-CMs with the MYH6-R443P variant exhibited dysmorphic sarcomeres and impaired contractility (slower contraction, reduced shortening, slower relaxation rates).
  • Sarcomere disorganization was observed in atrial, but not ventricular, tissues from HLHS patients with MYH6 variants.
  • CRISPR/Cas9 editing confirmed the MYH6-R443P variant's causal role in the observed phenotypes and its rescue upon correction.
  • Isoproterenol treatment did not improve iPSC-CM mechanics.

Conclusions:

  • The MYH6-R443P variant leads to sarcomere disorganization and impaired atrial cardiomyocyte contractility, contributing to HLHS.
  • Patient-derived iPSC-CMs are a valuable tool for understanding HLHS mechanisms.
  • Atrial dysfunction due to MYH6 variants may cause hemodynamic changes that impede left ventricular development in HLHS.